Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:November 17, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Atopic DermatitisLast Updated:November 17, 2022Completed
Condition(s):Rheumatoid ArthritisLast Updated:January 22, 2024Completed
Condition(s):Nonvalvular Atrial Fibrillation; Health, SubjectiveLast Updated:February 8, 2023Recruiting
Condition(s):Alzheimer’s DiseaseLast Updated:December 1, 2023Completed
Condition(s):Healthy VolunteersLast Updated:February 8, 2019Completed
Condition(s):Healthy SubjectsLast Updated:February 6, 2013Completed
Condition(s):TQT StudyLast Updated:March 13, 2020Completed
Condition(s):PharmacokineticsLast Updated:December 29, 2021Completed
Condition(s):Healthy SubjectsLast Updated:October 10, 2023Completed
Condition(s):Pharmacokinetics; Food Affect; Single Ascending Dose; Maximum Applicable DoseLast Updated:October 12, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.